Goldman Sachs Group Inc Lensar, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LNSR
# of Institutions
72Shares Held
5.05MCall Options Held
58.3KPut Options Held
19K-
North Run Capital, LP Wellesley, MA1.1MShares$13.6 Million7.54% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA545KShares$6.76 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX478KShares$5.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA442KShares$5.49 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny314KShares$3.89 Million0.01% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $137M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...